(Q67663083)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694612%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

title

Defining minimal requirements for antibody production to peptide antigens (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694612%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

31 October 2022

author name string

G. Goodman-Snitkoff

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694612

31 October 2022

L. E. Eisele

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694612

31 October 2022

E. P. Heimer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694612

31 October 2022

A. M. Felix

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694612

31 October 2022

T. T. Andersen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694612

31 October 2022

T. R. Fuerst

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694612

31 October 2022

R. J. Mannino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694612

31 October 2022

language of work or name

English

0 references

publication date

1 June 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694612%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 September 2019

number of pages

6

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:0264410X9090055Q?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

https://api.elsevier.com/content/article/PII:0264410X9090055Q?httpAccept=text/plain

31 October 2022

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

31 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694612%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694612%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694612%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

page(s)

257-262

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694612%20AND%20SRC:MED&resulttype=core&format=json

The immunology of new generation vaccines

16 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes

31 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Mouse response to influenza immunosomes.

31 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles

31 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant

31 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence

31 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Anti-influenza response achieved by immunization with a synthetic conjugate

31 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Antibodies to Hepatitis B Surface Antigen (HBsAg) Elicited by Immunization with a Synthetic Peptide Covalently Linked to Liposomes

31 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Protection of cattle against foot-and-mouth disease by a synthetic peptide.

31 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein.

31 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Research toward malaria vaccines

31 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC.

31 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Synthetic peptides: a next generation of vaccines?

31 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Immunological priming with synthetic peptides of foot-and-mouth disease virus

31 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Liposomes as immunological adjuvants

31 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Intranasal immunization with proteoliposomes protects against influenza

31 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Synthetic hepatitis B surface antigen peptide vaccine

31 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Liposomes as immunological adjuvants in eliciting antibodies specific to the synthetic polypeptide poly(LTyr, LGlu)‐poly(DLAla)–poly(LLys) with high frequency of site‐associated idiotypic determinants

31 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Rotary dialysis: its application to the preparation of large liposomes and large proteoliposomes (protein-lipid vesicles) with high encapsulation efficiency and efficient reconstitution of membrane proteins

31 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

The T cell response to the malaria circumsporozoite protein: an immunological approach to vaccine development

31 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Complete nucleotide sequence of the AIDS virus, HTLV-III

31 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

31 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Features of T-cell recognition and antigen structure useful in the design of vaccines to elicit T-cell immunity

31 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein

31 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Regulatory Mechanisms in the Immune Response to Cell-surface Antigens

31 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein

31 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site

31 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Proteosome-lipopeptide vaccines: enhancement of immunogenicity for malaria CS peptides

31 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes

31 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

Protein kinase activity associated with the avian sarcoma virus src gene product

31 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0264-410X(90)90055-Q

31 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694612%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference